shot-button

Get Your Mid-Day Gold Yearly Subscription now at Rs 899 Rs 499!

Home > News > India News > Article > INSACOG confirms first case of Omicron subvariant BA4 in India

INSACOG confirms first case of Omicron subvariant BA.4 in India

Updated on: 20 May,2022 07:50 PM IST  |  New Delhi
PTI |

INSACOG has also conducted a meeting and discussed the BA.4, the group of genetic laboratories are currently working to identify new variants

INSACOG confirms first case of Omicron subvariant BA.4 in India

Reprsentative image


India's first case of BA.4 subvariant of the Omicron strain of coronavirus was detected in Hyderabad through a genomic surveillance program, informed sources.


"The Indian SARS-CoV-2 Genomics Consortium (INSACOG) has confirmed the first case of the BA.4 Omicron variant in India has been reported from Hyderabad," sources told ANI.



INSACOG has also conducted a meeting and discussed the BA.4, the group of genetic laboratories are currently working to identify new variants.


"After detecting the first case of BA.4, the contact tracing has already been started of those who came in contact with a person who travelled to Hyderabad from South Africa. He was asymptomatic and the sample was collected on May 9," sources added.

The INSACOG will be releasing a medical bulletin on Monday.

Both the BA.4 and BA.5 variants of Omicron have been associated with the fifth COVID wave in South Africa and recently the US and Europe have also reported.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK